49.50
Precedente Chiudi:
$47.44
Aprire:
$47.51
Volume 24 ore:
1.34M
Relative Volume:
2.91
Capitalizzazione di mercato:
$2.69B
Reddito:
$1.24B
Utile/perdita netta:
$23.68M
Rapporto P/E:
117.86
EPS:
0.42
Flusso di cassa netto:
$108.67M
1 W Prestazione:
+3.82%
1M Prestazione:
+2.80%
6M Prestazione:
+6.22%
1 anno Prestazione:
-13.34%
Livanova Plc Stock (LIVN) Company Profile
Nome
Livanova Plc
Settore
Industria
Telefono
4402033250662
Indirizzo
20 EASTBOURNE TERRACE, LONDON
Confronta LIVN con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
LIVN
Livanova Plc
|
49.50 | 2.69B | 1.24B | 23.68M | 108.67M | 0.42 |
![]()
ABT
Abbott Laboratories
|
134.95 | 234.06B | 41.95B | 13.40B | 6.49B | 7.65 |
![]()
BSX
Boston Scientific Corp
|
104.39 | 154.06B | 16.75B | 1.85B | 2.37B | 1.25 |
![]()
SYK
Stryker Corp
|
387.92 | 148.02B | 22.60B | 2.99B | 3.49B | 7.76 |
![]()
MDT
Medtronic Plc
|
90.17 | 115.71B | 33.20B | 4.26B | 5.47B | 3.29 |
![]()
EW
Edwards Lifesciences Corp
|
72.76 | 42.91B | 5.72B | 4.17B | 490.10M | 6.97 |
Livanova Plc Stock (LIVN) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2024-10-04 | Iniziato | Goldman | Buy |
2024-09-17 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
2024-03-20 | Reiterato | Needham | Buy |
2024-02-20 | Aggiornamento | Mizuho | Neutral → Buy |
2023-09-06 | Iniziato | HSBC Securities | Hold |
2023-07-19 | Iniziato | Robert W. Baird | Neutral |
2023-04-14 | Iniziato | Mizuho | Neutral |
2022-12-21 | Iniziato | Barclays | Equal Weight |
2022-04-06 | Iniziato | Wolfe Research | Outperform |
2022-02-24 | Aggiornamento | UBS | Neutral → Buy |
2021-12-03 | Iniziato | Goldman | Buy |
2021-08-20 | Reiterato | Needham | Buy |
2021-07-20 | Aggiornamento | Needham | Hold → Buy |
2021-03-03 | Downgrade | Berenberg | Buy → Hold |
2021-01-05 | Downgrade | Needham | Buy → Hold |
2020-09-02 | Iniziato | Robert W. Baird | Outperform |
2020-06-26 | Reiterato | Needham | Buy |
2019-10-30 | Reiterato | Needham | Buy |
2019-02-28 | Reiterato | Needham | Buy |
2018-11-28 | Iniziato | UBS | Neutral |
2018-08-02 | Reiterato | Needham | Buy |
2018-06-08 | Iniziato | Stifel | Buy |
2018-05-31 | Reiterato | Needham | Buy |
2018-02-28 | Reiterato | Needham | Buy |
Mostra tutto
Livanova Plc Borsa (LIVN) Ultime notizie
LivaNova To Present At The Barclays Global Healthcare Conference -February 21, 2025 at 09:03 am EST - Marketscreener.com
LivaNova to Present at the Barclays Global Healthcare Conference - Business Wire
Global Magnetic Ablation Catheters Market Poised for Significant Growth, Projected to Reach USD 1,114.4 Million by 2035 Driven by Technological Advancements and Rising Cardiovascular Cases | Future Market Insights, Inc. - GlobeNewswire Inc.
U.S. Cardiac Resynchronization Therapy Market is projected - openPR
LivaNova (NASDAQ:LIVN) Stock Rating Upgraded by StockNews.com - MarketBeat
Allspring Global Investments Holdings LLC Trims Stake in LivaNova PLC (NASDAQ:LIVN) - MarketBeat
Vagus Nerve Stimulation Market Booming Trends: Future Growth, - openPR
Vagus Nerve Stimulators Market Witness Growth: Booming Demand, - openPR
LivaNova (NASDAQ:LIVN) Share Price Crosses Below 50 Day Moving AverageTime to Sell? - MarketBeat
Natalia Kozmina Joins LivaNova as Chief Human Resources Officer - MPO-mag
(LIVN) Pivots Trading Plans and Risk Controls - Stock Traders Daily
KBC Group NV Purchases 56,580 Shares of LivaNova PLC (NASDAQ:LIVN) - MarketBeat
LivaNova (NASDAQ:LIVN) Given "Buy" Rating at Needham & Company LLC - MarketBeat
Heart Valves Tester Market Surging Forward at 8.18% CAGR, Reaching 11.4 Billion USD by 2032 | Jotec GmbH, - EIN News
Getinge exits surgical perfusion, creating opportunity for Livanova - MedTech Dive
Cardiovascular Devices Market Detailed in New Research Report By 2032 | Livanova PLC, B. Braun Melsungen AG - openPR
Defibrillators Market registering a CAGR of 6.6% from 2021 - openPR
Stifel maintains LivaNova stock Buy rating, $72 target By Investing.com - Investing.com Australia
Stifel maintains LivaNova stock Buy rating, $72 target - MSN
Medical Implants Market Projected To Garner Significant Growth by 2024 -2031:Biotronik, Inc, Livanova Plc, - EIN News
Livanova PLC to Host Earnings Call - ACCESS Newswire
(LIVN) On The My Stocks Page - Stock Traders Daily
Artificial Heart Valve Market Trends is Electrifying Growth Cycle: Medtronic, LivaNova, CryoLife - openPR
Investor Network: Livanova PLC to Host Earnings Call - ACCESS Newswire
LivaNova (NASDAQ:LIVN) shareholders have endured a 35% loss from investing in the stock three years ago - Simply Wall St
Should You Sell LivaNova PLC (LIVN)? - Insider Monkey
LivaNova (NASDAQ:LIVN) Downgraded by StockNews.com to Buy - Defense World
LivaNova (NASDAQ:LIVN) Stock Rating Lowered by StockNews.com - MarketBeat
Vagus Nerve Stimulators Market is Estimated to Grow at a CAGR - openPR
Brokerages Set LivaNova PLC (NASDAQ:LIVN) PT at $69.17 - MarketBeat
LivaNova to Announce Fourth-Quarter and Full-Year 2024 Results - Business Wire
LivaNova's OSPREY Sleep Apnea Trail on aura6000 Meets Primary Endpoint - MSN
LIVN (LivaNova) EV-to-EBITDA : 53.85 (As of Jan. 20, 2025) - GuruFocus.com
Vagus Nerve Stimulators Market Growth in Future Scope 2025-2032 - openPR
StockNews.com Upgrades LivaNova (NASDAQ:LIVN) to Strong-Buy - MarketBeat
JPMorgan Chase & Co. Lowers Stock Position in LivaNova PLC (NASDAQ:LIVN) - Defense World
42,185 Shares in LivaNova PLC (NASDAQ:LIVN) Purchased by Harbor Capital Advisors Inc. - MarketBeat
Nordea Investment Management AB Acquires 12,470 Shares of LivaNova PLC (NASDAQ:LIVN) - MarketBeat
LivaNova PLC appoints Natalia Kozmina as Chief Human Resources Officer - ETHRWorld Middle East
LivaNova Appoints Natalia Kozmina as Chief Human Resources Officer - Business Wire
Electroceuticals Market Top Companies StudyMedtronic Plc - openPR
Principal Financial Group Inc. Has $9.01 Million Position in LivaNova PLC (NASDAQ:LIVN) - MarketBeat
Sanctuary Advisors LLC Acquires Shares of 4,268 LivaNova PLC (NASDAQ:LIVN) - Defense World
LivaNova PLC's (NASDAQ:LIVN) Price Is Right But Growth Is Lacking - Simply Wall St
LivaNova PLC (NASDAQ:LIVN) Receives Consensus Rating of "Buy" from Analysts - MarketBeat
(LIVN) Investment Report - Stock Traders Daily
LivaNova (NASDAQ:LIVN) Lowered to Buy Rating by StockNews.com - MarketBeat
Vagus Nerve Stimulators Market Growth in Future Scope 2024-2031 - openPR
Livanova Plc Azioni (LIVN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):